Cite
Gerarduzzi C, Kumar RK, Trivedi P, et al. Silencing SMOC2 ameliorates kidney fibrosis by inhibiting fibroblast to myofibroblast transformation. JCI Insight. 2017;2(8)doi: 10.1172/jci.insight.90299.
Gerarduzzi, C., Kumar, R. K., Trivedi, P., Ajay, A. K., Iyer, A., Boswell, S., Hutchinson, J. N., Waikar, S. S., & Vaidya, V. S. (2017). Silencing SMOC2 ameliorates kidney fibrosis by inhibiting fibroblast to myofibroblast transformation. JCI insight, 2(8), . https://doi.org/10.1172/jci.insight.90299
Gerarduzzi, Casimiro, et al. "Silencing SMOC2 ameliorates kidney fibrosis by inhibiting fibroblast to myofibroblast transformation." JCI insight vol. 2,8 (2017). doi: https://doi.org/10.1172/jci.insight.90299
Gerarduzzi C, Kumar RK, Trivedi P, Ajay AK, Iyer A, Boswell S, Hutchinson JN, Waikar SS, Vaidya VS. Silencing SMOC2 ameliorates kidney fibrosis by inhibiting fibroblast to myofibroblast transformation. JCI Insight. 2017 Apr 20;2(8). doi: 10.1172/jci.insight.90299. eCollection 2017 Apr 20. PMID: 28422762; PMCID: PMC5396522.
Copy
Download .nbib